T-cell lymphoma: the CAR-T revolution is coming

In this issue of Blood, Hill et al demonstrate the safety and feasibility of chimeric antigen receptor T (CAR T) cells targeting CD5 in treating patients with relapsed and refractory mature T-cell lymphoma

Authors

Institutions

Publication Details

Journal
UNC Libraries
Published
2025-03-29
DOI
https://doi.org/10.17615/5sz1-e525
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

T-cell lymphoma: the CAR-T revolution is coming

Natalie Sophia Grover, Anne W. Beaven
UNC Libraries
CAR-T cell therapy research
article

T-cell lymphoma: the CAR-T revolution is coming

Natalie Sophia Grover, Anne W. Beaven
article en

Abstract

In this issue of Blood, Hill et al demonstrate the safety and feasibility of chimeric antigen receptor T (CAR T) cells targeting CD5 in treating patients with relapsed and refractory mature T-cell lymphoma

UNC Libraries
University of North Carolina at Chapel Hill (US)
Openalex Percentile: Top 61%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

T-cell lymphoma: the CAR-T revolution is coming — Natalie Sophia Grover, Anne W. Beaven · UNC Libraries (2025) | TGRS Research Map | TGRS